Tandlægerne Classensgade ved Mia og Anders Byrel ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  8.3% 4.7% 3.5% 3.6% 3.2%  
Credit score (0-100)  31 46 52 52 55  
Credit rating  BB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  2,472 4,286 5,357 7,496 8,077  
EBITDA  551 1,029 792 1,501 1,643  
EBIT  133 552 292 944 1,197  
Pre-tax profit (PTP)  -49.6 393.2 136.8 759.5 1,009.9  
Net earnings  -38.8 305.4 132.3 557.1 785.3  
Pre-tax profit without non-rec. items  -49.6 393 137 760 1,010  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  1,086 1,008 673 546 1,978  
Shareholders equity total  -332 -26.6 106 663 1,248  
Interest-bearing liabilities  2,913 2,358 1,990 1,729 2,487  
Balance sheet total (assets)  3,241 3,519 3,420 3,573 6,710  

Net Debt  2,797 1,911 1,245 767 1,184  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,472 4,286 5,357 7,496 8,077  
Gross profit growth  51.9% 73.4% 25.0% 39.9% 7.8%  
Employees  4 6 9 9 9  
Employee growth %  33.3% 50.0% 50.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,241 3,519 3,420 3,573 6,710  
Balance sheet change%  -4.7% 8.6% -2.8% 4.5% 87.8%  
Added value  550.7 1,029.0 792.5 1,445.1 1,643.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -666 -650 -931 -778 2,260  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  5.4% 12.9% 5.4% 12.6% 14.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  3.7% 15.5% 8.5% 27.1% 23.3%  
ROI %  4.2% 21.0% 13.3% 41.1% 37.0%  
ROE %  -1.2% 9.0% 7.3% 145.0% 82.2%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  -9.3% -0.7% 3.1% 18.8% 18.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  508.0% 185.7% 157.1% 51.1% 72.1%  
Gearing %  -877.5% -8,877.4% 1,882.5% 260.9% 199.3%  
Net interest  0 0 0 0 0  
Financing costs %  5.8% 6.1% 7.3% 10.1% 8.9%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.3 0.6 0.7 1.2 0.6  
Current Ratio  0.3 0.6 0.7 1.1 0.6  
Cash and cash equivalent  115.9 447.3 745.6 962.4 1,303.1  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -934.1 -632.3 -462.6 166.5 -1,509.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  138 172 88 161 183  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  138 172 88 167 183  
EBIT / employee  33 92 32 105 133  
Net earnings / employee  -10 51 15 62 87